Novel (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors deriving from the renovation of coumarin skeletons: Design, synthesis, characterization and antineoplastic activity
Bioorganic & Medicinal Chemistry · 2026-09 · 140 · 118730
DOI: 10.1016/j.bmc.2026.118730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026-09. Verfasst von Ruiying Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Ocean Engineering Technology, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Jiangsu Ocean University, Lianyu…. Hauptthemen laut MEDLINE: ErbB Receptors, Antineoplastic Agents, Coumarins, Drug Design. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Ocean University.
Abstract (Originalsprache)
The inhibitors of epidermal growth factor receptor (EGFR) have emerged as one of fastest-growing medications that are widely utilized to control the spread and proliferation of malignant tumors. Based on the structural features of quinazoline-containing EGFR inhibitors, a series of coumarin-deriving (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors were firstly constructed and evaluated for their antiproliferative effects against human pancreatic (PANC-1), gastric (SGC7901), hepatocellular (HepG2), breast (MDA-MB-231) and cervical (Hela) carcinoma cells. Strikingly, the IC50 values of a target molecule 5x against SGC7901 and MDA-MB-231 cells were respectively evaluated as 12.82 and 9.97 μM, which were slightly superior to that of fluorouracil (21.23 and 10.67 μM). Concurrently, the further investigations indicated that constructed (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates could evidently effect the colony formation, migration, invasion and adhesion of tumour cells in a dose-dependent manner. Subsequently, the feasibility of constructed (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors was ascertained by the relative surveys on molecular docking and molecular dynamics simulation analyses. This present work provided a necessary replenishment for the structural optimizations of quinazoline-containing EGFR inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Ocean Engineering Technology, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Jiangsu Ocean University, Lianyungang 222005, China.
- Research Center of Ocean Engineering Technology, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Jiangsu Ocean University, Lianyungang 222005, China; State Key Laboratory of Green Pesticide, Key Labo…
- State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang 550025, China.
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Jiangsu Ocean University
Zitieren
APA
Wang, R., Wang, S., Ren, X., Chen, H., Liu, W., Gu, J., Si, X., Wang, X., & Xue, W. (2026). Novel (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors deriving from the renovation of coumarin skeletons: Design, synthesis, characterization and antineoplastic activity. Bioorganic & Medicinal Chemistry, 140, 118730. https://doi.org/10.1016/j.bmc.2026.118730
Vancouver
Wang R, Wang S, Ren X, Chen H, Liu W, Gu J, et al. Novel (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors deriving from the renovation of coumarin skeletons: Design, synthesis, characterization and antineoplastic activity. Bioorganic & Medicinal Chemistry. 2026;140:118730. doi:10.1016/j.bmc.2026.118730
BibTeX
@article{Wang2026,
author = {Wang, Ruiying and Wang, Siqi and Ren, Xiaona and Chen, Huajian and Liu, Wei and Gu, Jingyi and Si, Xinxin and Wang, Xiaobin and Xue, Wei},
title = {Novel (Z)-3-(2-(quinazolin-4-yloxy)phenyl)acrylates as potential EGFR inhibitors deriving from the renovation of coumarin skeletons: Design, synthesis, characterization and antineoplastic activity},
journal = {Bioorganic & Medicinal Chemistry},
year = {2026},
volume = {140},
pages = {118730},
doi = {10.1016/j.bmc.2026.118730}
}
EUVIMED